Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,711 | -16,859 | -9,139 | -3,898 | -17,837 |
| Depreciation Amortization | 755 | 637 | 351 | 176 | 755 |
| Accounts payable and accrued liabilities | 1,780 | 2,088 | 486 | 1,771 | 504 |
| Other Working Capital | 2,778 | 3,080 | 941 | -137 | -1,209 |
| Other Operating Activity | 1,172 | -367 | 85 | -1,447 | 5,653 |
| Operating Cash Flow | $-18,226 | $-11,421 | $-7,276 | $-3,535 | $-12,134 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -79 | -65 | -39 | -31 | -586 |
| Investing Cash Flow | $-79 | $-65 | $-39 | $-31 | $-586 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 500 |
| Debt Repayment | -113 | -97 | -69 | -35 | -451 |
| Common Stock Issued | 28,662 | 28,637 | 27,933 | 111 | 44,870 |
| Other Financing Activity | -781 | -577 | -486 | 0 | 5,024 |
| Financing Cash Flow | $27,768 | $27,963 | $27,378 | $76 | $49,943 |
| Beginning Cash Position | 39,866 | 39,866 | 39,866 | 39,866 | 2,643 |
| End Cash Position | 49,329 | 56,343 | 59,929 | 36,376 | 39,866 |
| Net Cash Flow | $9,463 | $16,477 | $20,063 | $-3,490 | $37,223 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,226 | -11,421 | -7,276 | -3,535 | -12,134 |
| Capital Expenditure | -79 | -65 | -39 | -31 | -586 |
| Free Cash Flow | -18,305 | -11,486 | -7,315 | -3,566 | -12,720 |